chronic obstructive pulmonary disease (COPD)
Conditions
Interventions
AECOPD experimental group(Group ABCD):Intravenous glucocorticoids
COPD Stabilization Group:None
Health Group:None
Sponsors
The Second People's Hospital of Fuyang City
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Healthy people; patients over 40 years of age with stable COPD diagnosed by pulmonary function; patients with a clear diagnosis and no history of acute exacerbation in the last 3 months, and patients with regular inhalation medication for AECOPD. All those who voluntarily participate and can complete the trial.
Exclusion criteria
Exclusion criteria: Patients with chronic cough (more than 8 weeks of illness), bronchial asthma, bronchiectasis, lung cancer, sleep apnea-hypopnea syndrome caused by various causes; Patients with long-term oral or intravenous glucocorticoids, allergy to glucocorticoids, coronary heart disease, hypertension, heart failure and diabetes, liver and kidney diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| alveolar nitric oxide;eosinophil count; | — |
Countries
China
Contacts
Public ContactYa Shen
The Second People's Hospital of Fuyang City
Outcome results
None listed